Skip to main content
Caplight Logo









Unorthodox Ventures

Unorthodox Ventures

Overview

Unorthodox Ventures is an American-based institutional investor focused on partnering with innovative, driven founders. The firm distinguishes itself by adopting a hands-on, operator-centric approach to investing, focusing on early-stage companies that develop innovative solutions to real-world problems. Unorthodox Ventures emphasizes long-term success over short-term gains, partnering with founders who demonstrate both disruption and discipline. They invest in medical technology (medtech) and construction technology (contech), particularly targeting companies in the cardiology and gastrointestinal sectors, as well as those developing software to enhance job-site productivity.

Year Founded

2017

Portfolio Companies

22

Investments

Unorthodox Ventures investments
CompanyDateStageLead
Supira MedicalMar 2025Series ECo-investor
Akura MedicalDec 2025Series CCo-investor
Adona MedicalJul 2024Series CCo-investor
ANINA Culinary ArtSep 2022SeedCo-investor
CorFlow Therapeutics AGSep 2024Series BCo-investor
Book a demo to see all 22 portfolio companies

For institutional investors. Book with your work email.

Key People

Adam Kahn

Principal

Anderson Smith

Principal

Brian Smith

Principal

Cuinn Alexander

Principal

Daniel Allen

Principal

Gavin Holiday

Principal

Lewis Kasindi Kilongo

Principal

Tristan Smith

Principal

Book a demo to see all key people

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Unorthodox Ventures based?

Unorthodox Ventures is headquartered in Austin, Texas, United States.

When was Unorthodox Ventures founded?

Unorthodox Ventures was founded in 2017.

How many portfolio companies does Unorthodox Ventures have?

Unorthodox Ventures has 22 portfolio companies in Caplight's dataset.

What are some companies in Unorthodox Ventures's portfolio?

Portfolio companies visible on Caplight include Supira Medical, Akura Medical, Adona Medical, ANINA Culinary Art, CorFlow Therapeutics AG.

What was Unorthodox Ventures's most recent investment shown here?

Unorthodox Ventures's most recent investment in this portfolio sample was in Akura Medical in 2025.

What sectors does Unorthodox Ventures focus on?

Unorthodox Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Consumer & Commerce, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Consumer & Commerce, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech.

What company stages does Unorthodox Ventures focus on?

Unorthodox Ventures typically invests at the MultiStage stage.

What is Unorthodox Ventures's AUM?

Unorthodox Ventures's assets under management are estimated between $50.0M and $100.0M.

Firmographic Details

HeadquartersAustin, Texas
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?